SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-103108
Filing Date
2020-04-10
Accepted
2020-04-10 08:01:03
Documents
3
Period of Report
2020-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d912494d8k.htm 8-K 22010
2 EX-99.1 d912494dex991.htm EX-99.1 11819
3 GRAPHIC g912494g02z38.jpg GRAPHIC 7600
  Complete submission text file 0001193125-20-103108.txt   45592
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 20785954
SIC: 2836 Biological Products, (No Diagnostic Substances)